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Mechanistic Target of Rapamycin 
Complex 1 Promotes the 
Expression of Genes Encoding 
Electron Transport Chain Proteins 
and Stimulates Oxidative 
Phosphorylation in Primary Human 
Trophoblast Cells by Regulating 
Mitochondrial Biogenesis
Fredrick J. Rosario1, Madhulika B. Gupta2, Leslie Myatt3, Theresa L. Powell1,4, 
Jeremy P. Glenn5, Laura Cox5,6 & Thomas Jansson1
Trophoblast oxidative phosphorylation provides energy for active transport and protein synthesis, 
which are critical placental functions influencing fetal growth and long-term health. The molecular 
mechanisms regulating trophoblast mitochondrial oxidative phosphorylation are largely unknown. We 
hypothesized that mechanistic Target of Rapamycin Complex 1 (mTORC1) is a positive regulator of key 
genes encoding Electron Transport Chain (ETC) proteins and stimulates oxidative phosphorylation in 
trophoblast and that ETC protein expression is down-regulated in placentas of infants with intrauterine 
growth restriction (IUGR). We silenced raptor (mTORC1 inhibition), rictor (mTORC2 inhibition) or 
DEPTOR (mTORC1/2 activation) in cultured term primary human trophoblast (PHT) cells. mTORC1 
inhibition caused a coordinated down-regulation of 18 genes encoding ETC proteins representing 
all ETC complexes. Inhibition of mTORC1, but not mTORC2, decreased protein expression of ETC 
complexes I–IV, mitochondrial basal, ATP coupled and maximal respiration, reserve capacity and 
proton leak, whereas activation of mTORC1 had the opposite effects. Moreover, placental protein 
expression of ETC complexes was decreased and positively correlated to mTOR signaling activity in 
IUGR. By controlling trophoblast ATP production, mTORC1 links nutrient and O2 availability and growth 
factor signaling to placental function and fetal growth. Reduced placental mTOR activity may impair 
mitochondrial respiration and contribute to placental insufficiency in IUGR pregnancies.
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The placenta constitutes the primary maternal-fetal interface and its immunologic, transport, metabolic and 
endocrine functions are critical for normal fetal growth and development. The syncytiotrophoblast, the trans-
porting and hormone-producing epithelium of the human placenta, requires a large amount of energy in the form 
of ATP to support processes such as active transport and protein synthesis. These ATP needs are met, in part, by 
mitochondrial respiration, however the molecular mechanisms regulating oxidative phosphorylation in primary 
human trophoblast (PHT) cells are largely unknown.
As in other cells, syncytiotrophoblast mitochondria are critical for a multitude of biological processes includ-
ing energy metabolism, redox signaling, steroid synthesis, and apoptosis1. Impaired placental mitochondrial 
function2 and ATP production, placental insufficiency3,4, and hypoxia3 may act in concert to reduce fetal growth. 
Perturbations in trophoblast mitochondrial function could lead to excessive generation of reactive oxygen and 
nitrogen species5, contributing to altered placental function in IUGR, gestational diabetes, and maternal obe-
sity6–8. Moreover, placental mitochondrial dysfunction has been implicated in the programming of atherosclero-
sis in cases of placental insufficiency5.
Mechanistic Target of Rapamycin (mTOR) is a serine/threonine kinase that is activated by amino acids, glu-
cose, oxygen and growth factor signaling and promotes cell growth and metabolism. mTOR exists in two com-
plexes, mTOR Complex 1 (mTORC1) and 2, with the protein Regulatory-associated protein of mTOR (Raptor) 
associated to mTORC1 and Rapamycin-insensitive companion of mammalian target of rapamycin (Rictor) 
associated to mTORC2. When activated, mTORC1 phosphorylates p70 ribosomal protein S6 kinase 1 (S6K1) 
and 4E-binding protein 1 (4E-BP1) promoting protein translation, lipid biogenesis and metabolism as well as 
suppressing autophagy9–14. mTORC2 phosphorylates protein kinase B (AKT), Protein kinase C alpha (PKCα) 
and Serum and Glucocorticoid-regulated Kinase 1 (SGK1) and regulates cytoskeletal organization and metabo-
lism15,16. DEPTOR, a protein containing two DEP (Dishevelled, Egl-10, Pleckstrin) domains, is an endogenous 
inhibitor of both mTORC1 and 2 signaling17. Placental mTOR activity is decreased in human intrauterine growth 
restriction (IUGR)18–20 as well as in rodent21 and non-human primate models of IUGR22. On the other end of 
the fetal growth spectrum, placental mTOR activity is activated in obese women giving birth to larger babies23 
as well as in a mouse model of maternal obesity associated with fetal overgrowth24. We recently demonstrated 
that placental mTOR functions as a positive regulator of amino acid transporter system A and L25 and folate 
transporters26.
mTORC1 activation increases mitochondrial DNA copy number and promotes the expression of genes crit-
ical for mitochondrial metabolism27,28 including genes encoding for proteins involved in oxidative phosphoryl-
ation29,30. Recent studies in MCF7 cells suggest that mTORC1 controls mitochondrial activity and biogenesis 
through 4E-BP1 dependent translation31. Furthermore, rapamycin-treated leukemic cells display reduced mito-
chondrial function, resulting in energy production via enhanced aerobic glycolysis in preference over mitochon-
drial respiration31. However, the mechanisms involved and the specific role of mTORC1 and mTORC2 signaling 
in the regulation of mitochondrial respiration in the placenta remain to be established.
Using gene silencing approaches in cultured primary human trophoblast cells and studies of placental tissue 
from normal and IUGR pregnancies we tested the hypothesis that mTORC1 is a positive regulator of key genes 
encoding Electron Transport Chain (ETC) proteins and stimulates oxidative phosphorylation in trophoblast and 
that ETC protein expression is down-regulated in placentas of infants with intrauterine growth restriction.
Materials and Methods
Ethical Approval and Study Participants. PHT cells were isolated from placentas of uncomplicated term 
pregnancies collected with informed consent at the Labor and Delivery Unit at University Hospital San Antonio 
with approval of the Institutional Review Board of the University of Texas Health Science Center San Antonio. 
Placentas from pregnancies complicated by intrauterine growth restriction (IUGR) and women delivering appro-
priate-for-gestational age (AGA) infants were collected at St. Joseph’s Health Care Centre, London, Ontario, 
Canada. These women were enrolled after informed consent was obtained, according to a protocol approved by 
the University of Western Ontario Health Sciences Research Ethics Board. The recruitment procedure, including 
inclusion and exclusion criteria, has been described in detail previously20. All experimental protocols and meth-
ods were approved by a University of Texas Health Science Center San Antonio committee and St. Joseph’s Health 
Care Centre, London, Ontario, Canada. The informed consent was obtained from all subjects.
Materials
Oligomycin, FCCP [4-(trifluoromethoxy) phenylhydrazone], and antimycin A were obtained from Sigma and 
dissolved in DMSO as 2.5 mM stock solutions. A human oxidative phosphorylation (OXPHOS) antibody cocktail 
and antibodies targeting NDUFB8, TOM20, Cytochrome b and c antibodies were purchased from Abcam. Raptor 
and rictor antibodies were obtained from Cell Signaling Technology.
Isolation and Culture of Primary human Trophoblasts (PHT). Placentas were collected immediately 
following delivery by cesarean section at term without labor. PHT cells were isolated and cultured in vitro using a 
well-established protocols26,32. Cells were plated in either 60 mm culture dishes (~7.5 × 106 cells/dish for RNA iso-
lation or Western blot analysis) or in Seahorse XF-24 plates for mitochondrial respiration experiments (~8 × 105 
cells/well for RNAi mediated gene silencing) and cultured in 5% CO2, 95% atmosphere air at 37 °C for 90 h. Cell 
culture media (DMEM/Hams F-12, supplemented with L-glutamine, penicillin, streptomycin, gentamycin, and 
10% fetal bovine serum) was changed daily. The study design, including the time point of siRNA mediated silenc-
ing/activation of mTORC1/C2 signaling and measurements of various parameters, is illustrated in Supplemental 
Fig. 1.
Mononuclear cytotrophoblast cells isolated from term placentas typically start to aggregate into monolayers of 
mononucleated cells within about 12 h of plating. By 72 h in culture, most cytotrophoblast cells have differentiated 
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into multinuclear syncytiotrophoblast as evidenced by the expression of cytokeratin-7, a trophoblast specific 
marker, and secretion of human chorionic gonadotropin-β (β-hCG), produced exclusively by syncytiotropho-
blast33,34. Furthermore, we recently reported that in our cultured PHT cells expression of syncytin, a marker of 
syncytialization cells increased over the culture period confirming syncytialization of our cell population35. Cell 
viability and degree of syncytialization are maintained to beyond 90 hours in culture25,36 allowing investigators 
to study syncytiotrophoblast function between 72 and 90 h. Studies at 90 h in culture ensure that maximum gene 
silencing has been achieved following siRNA transfection at 18 hours in culture, as in the current report.
RNA interference-mediated silencing. Dharmafect 2 transfection reagent (Thermo Scientific, Rockford, 
IL) and small interfering RNAs (siRNAs) (Sigma-Aldrich, St. Louis, MO), targeting raptor (100 nM; sense, 
5′CAGUUCACCGCCAUCUACA), rictor (100 nM; sense, 5′CGAUCAUGGGCAGGUAUUA), or DEPTOR 
(SASI_1297010-H/5582, 1297011-H) were used. Control cells were transfected with a non-coding scrambled 
sequence (100 nM; sense: 5′GAUCAUACGUGCGAUCAGATT). siRNA were added to cultured primary troph-
oblast cells (~8 × 105 cells/well in 24 well plate; ~7.5 × 106 cells in 60 mm dish) after 18 h in culture, incubated for 
24 h, and removed, and fresh medium was added to wells37. At 90 hours in culture, efficiency of target silencing 
was determined at the protein level (expression of raptor, rictor or DEPTOR) using Western blot.
RNA isolation from PHT cells. RNA was isolated from cultured PHT cells at 90 hr in culture using TRIzol 
Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. RNA was resuspended in 100 µl 
DEPC-treated water. RNA quality was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., 
Santa Clara, CA) and RNA concentrations confirmed by quantitation using a NanoDrop™ 8000 spectrophotome-
ter (Thermo Fisher Scientific, Wilmington, DE).
Gene expression profiling in PHT cells. Whole genome expression profiling was performed using gene 
arrays (HumanHT-12 v4 Expression BeadChips, Illumina Inc., San Diego, CA). cRNA was synthesized and bio-
tin labeled (cat. no. 1750, Ambion, Austin, TX) according to manufacturer’s instructions. Total RNA was used 
for first and second strand cDNA synthesis followed by in vitro transcription to synthesize biotin-labeled cRNA. 
Following quality check, cRNA was hybridized to Human HT-12 v4 Expression BeadChips (Illumina Inc.). 
Individual cRNA samples were used to interrogate each BeadChip (Scramble siRNA for raptor, n = 4; Raptor 
siRNA, n = 4; Scramble siRNA for rictor, n = 4; Rictor siRNA, n = 4). Gene expression was detected and cleaned 
using GenomeStudio software (Illumina Inc.) and filtered using quality score (>0.95). Gene array data were 
all-median normalized and log2 transformed (GeneSifter), and differentially expressed genes were identified by 
t-test (p < 0.05). Genes significantly different in expression were overlaid onto Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways38–40 using GeneSifter. Z-scores were calculated in GeneSifter. Statistical enrichment 
of differentially expressed genes in pathways was determined by calculating z-scores using the following formula: 
z-score = (r − n(R/N))/SQRT(n(R/N) (1 − (R/N))(1 − (n − 1/N − 1)); where R = total number of genes meeting 
selection criteria, N = total number of genes measured, r = number of genes meeting selection criteria with the 
specified GO term, and n = total number of genes measured with the specific GO term. Pathway enrichment 
analysis of differentially expressed genes has been shown to reveal pathways that are impacted in that biological 
system41. KEGG is a comprehensive knowledge base for assisting in the biological interpretation of large-scale 
molecular datasets. Using KEGG pathway enrichment analysis provides a means to statistically filter gene expres-
sion data within the framework of annotated biological systems38. Calculations were performed using GeneSifter 
software default settings without user input. Pathways were considered significantly different between groups if 
the z-score for that pathway was greater than +2.0 or less than −2.042. Biological pathways were mapped by using 
online tool KEGG (http://www.genome.jp/kegg/; Kyoto encyclopedia for genes and genomes)38–40,43.
Western blotting. Cells were rinsed once with ice-cold PBS and lysed in ice-cold buffer (PBS containing 
0.05% SDS and protease, phosphatase inhibitor). Subsequently, cells were scraped, collected, and sonicated. 
The soluble fraction of cell lysates were isolated by centrifugation at 13,000 g for 10 min at 4 °C. Total protein 
concentration in the cell lysate was determined using Bradford’s reagent (Bio-Rad). Cell lysate proteins (10 μg) 
were separated on 4–20% precast linear gradient gels (Invitrogen). Membranes were incubated overnight 
at 4 °C with primary antibody diluted in 1% nonfat milk (wt/vol) in TBST and detected using an appropriate 
peroxidase-conjugated secondary antibody. Products were visualized by ECL chemiluminescence (Millipore). 
Band intensities were measured using the G-box system (Syngene). Anti-β actin was from Sigma-Aldrich, St. 
Louis, Mo. Target band densities were normalized to loading using beta-actin. For each protein target the mean 
density of the control sample bands was assigned an arbitrary value of 1. All individual densitometry values were 
expressed relative to this mean.
Assessment of Mitochondrial Function. Mitochondrial function in PHT cells was measured using a 
Seahorse XF24 analyzer (Seahorse Biosciences) as described44. The experimental details explaining the measure-
ment of Oxygen Consumption Rate (OCR) in PHT cells is provided as Supplemental Material. Basal respiration 
was calculated from four baseline OCR readings. ATP coupled, maximum respiration, reserve capacity, proton 
leak, and non-mitochondrial respiration were calculated from OCR readings following the injection of oligomy-
cin (1 μM), FCCP (1 μM), and antimycin A (1.5 μM).
PHT cell ATP Levels. ATP levels were determined in cell lysates at 90 hr of culture using the Enliten ATP 
assay (Promega) according to the manufacturer’s protocol.
Mitochondrial Biogenesis. Mitochondrial DNA copy number. At 90 hr of culture total genomic DNA 
was isolated from cultured PHT cells using the GenElute Mammalian Genomic DNA Miniprep Kit 
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(Sigma-Aldrich). Mitochondrial DNA copy number was determined using the Nuvaquant human mito/nuclear 
DNA ratio kit (Calbiochem) involving real-time PCR and using primers for mitochondrial 16S rRNA and nuclear 
β2-microglobulin according to the manufacturer’s protocol.
Citrate synthase activity. Was measured in PHT cell lysates at 90 hr of culture using a commercial kit from 
Detroit R&D according to the manufacturer’s protocol. Cultured PHT cells were homogenized using lysis reagent 
(C3228; Sigma).
Staining of mitochondria in PHT cells. Isolated PHT cells (500,000 cells/well) were grown on chamber slides 
(Lab-Tek) for 90 hours. At 90 hr, cells were incubated with mito green indicator (Abcam) in a 37 °C, 5% CO2 
for 10 minutes. Subsequently, cells were fixed in paraformaldehyde (4%) for 20 min. Confocal microscopy was 
performed using Zeiss LSM 780 microscope at 63x magnification using oil immersion. Images were captured in 
the same laser settings with four Z-step of 0.4 um. For densitometric analysis of mitochondrial staining, Image J 
Software (version 1.52a) was used. In each section, at least five randomly selected microscopic fields were used to 
calculate mitochondria staining density per mm2 and data were averaged to represent a single placenta.
Placental mTORC1 signaling and expression of mitochondrial electron transport complexes in 
IUGR. Placentas from pregnancies complicated by intrauterine growth restriction (IUGR) and women deliv-
ering appropriate-for-gestational age (AGA) infants were collected within 15 minutes of delivery as described 
elsewhere20. Selected clinical data for the control and IUGR groups are listed in Table 1. There was no significant 
difference in maternal age, body mass index (BMI) or gestational age between the control and the IUGR groups. 
Birth weight was 28% lower (P < 0.01) and placental weight was reduced by 36% (P < 0.001) in the IUGR group 
compared with controls. The decidua basalis and chorionic plate were removed and villous tissue was dissected 
and rinsed in cold physiological saline. The villous tissue was transferred to cold buffer D (250 mM sucrose, 
10 mM HEPES, pH 7.4) containing 1:100 dilution of protease and phosphatase inhibitors (Sigma-Aldrich, St. 
Louis, MO) and homogenized on ice with a Polytron (Kinematica, Luzern, Switzerland). Placental homogen-
ates were frozen in liquid nitrogen and stored at −80 °C until further processing. The phosphorylation of key 
proteins in the mTORC1 [as reported in20], raptor, rictor, DEPTOR and mitochondrial electron transport com-
plexes expression in placental homogenates of IUGR and control group were determined using Western blots as 
described above for cells.
Data presentation and statistics. The number of experiments (n) represents the number of placentas 
studied. Each condition was studied in triplicate, and data were averaged to represent trophoblast cells iso-
lated from one placenta. Data are presented as means ± S.E.M or + S.E.M. Array data from each sample were 
all-median normalized and log2 transformed. Statistical analyses of array data were performed by t-test using 
GeneSifter software (Geospiza, Inc.) for pairwise comparisons (GeneSifter.Net, VizX Labs, Seattle, WA; GEO 
accession number: GSE40878). Statistical significance of differences between control and experimental groups 
in studies of protein expression and mitochondrial function was assessed using Student’s t-test. A P-value < 0.05 
was considered significant.
Results
Validation of silencing efficiency. To confirm that the siRNA reduced expression of the proteins 
encoded by the targeted genes, we performed western blots on siRNA-transfected PHT cells at 90 h of culture 
(Supplemental Fig. 2). Raptor or rictor siRNA silencing in PHT cells (Supplemental Fig. 2; n = 4/each group) 
markedly decreased the protein expression of raptor and rictor, respectively.
Inhibition of mTORC1 caused a decrease in expression of genes involved in oxidative phospho-
rylation. In a separate unpublished study we used whole genome expression profiling in raptor (mTORC1 
inhibition) and rictor (mTORC2 inhibition) silenced PHT cells as an approach to identify novel trophoblast 
functions regulated by mTOR signaling. Leveraging this discovery data set we specifically asked the question 
if trophoblast mTORC1 regulates the transcription of genes encoding ETC proteins, in analogy with other cell 
types27,45,46. Indeed, expression of 18 genes encoding ETC proteins representing all five complexes involved in 
mitochondrial respiration was all down-regulated in response to raptor silencing (Supplemental Fig. 3), but not 
Control (n = 19) IUGR (n = 25)
Maternal age (years) 25.9 ± 1.29 28.7 ± 1.23
BMI (kg/m2)* 28.3 ± 2.6 26.8 ± 2.0
Gestational age (weeks) 33.9 ± 0.95 35.7 ± 0.61
Birth weight (g) 2493 ± 236 1804 ± 110†
Birth weight percentile‡ 55.9 ± 4.6 2.4 ± 0.3§
Placental weight (g) 566 ± 42.0 394 ± 18.4||
Fetal sex (M/F) 7/12 8/17
Mode of delivery (C/V) 6/13 15/10
Table 1. Selected clinical data. Data are presented as means ± S.E.M. Abbreviations: C, caesarean section; 
F, female; M, male; n, numbers; V, vaginal delivery. *n = 10 (control) and 18 (IUGR); ‡by corresponding 
gestational age; †P < 0.05; ||P < 0.01; §P < 0.0001.
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following rictor silencing (data not shown). In agreement with these findings, mitochondrial oxidative phos-
phorylation was one of the top ranked down-regulated pathways following mTORC1 inhibition using the Kyoto 
Encyclopedia of Genes and Genomes (KEGG; Supplemental Fig. 3).
Effect of mTORC1 or mTORC2 inhibition on protein expression of electron transport chain 
complexes. Energy derived from the oxidation of carbohydrates, fats and proteins are transformed to ATP 
by the mitochondrial respiratory chain which is composed of five separate protein complexes (I–V) present in 
the inner mitochondrial membrane47. To confirm that the observed down-regulation of genes involved in mito-
chondrial respiration was associated with corresponding changes in protein expression, we performed Western 
blotting on mitochondrial complexes using an antibody cocktail (Total OXPHOS Human WB Antibody Cocktail 
(ab110411), abcam, UK), recognizing epitopes of purified subunits of II (SDHB), III (UQCRC2), IV (MTCOX1), 
and V (ATP5α). Total OXPHOS Human WB Antibody Cocktail did not detect Complex I (NDUFB8) in PHT cell 
lysates so we used Anti-NDUFB8 antibody (ab155903) for this purpose. Inhibition of mTORC1 decreased the 
expression levels of subunits of complexes I, II, III, IV and V as compared to control (n = 4/each group; Fig. 1). 
In contrast, protein expression of mitochondrial complexes was unaffected by mTORC2 inhibition (n = 4/each 
group; Fig. 1).
Effect of mTORC1 inhibition on TOM20 (translocase of the outer membrane 20) protein expres-
sion in PHT cells. Biogenesis of functional and competent mitochondria requires the import and assembly 
of proteins synthesized in the cytoplasm. Mitochondria contain more than 1000 proteins that are imported from 
the cytoplasm through the translocase of the outer mitochondrial membrane (TOM complex). Proteins to be 
translocated into the mitochondria are targeted by the presequence receptors Tom20 or Tom70 and enter the 
mitochondria via the pore, which is mainly formed by Tom4048. Cytochrome b (Cyt b) is an integral part of 
Complex III, and in its absence the entire complex will fail to assemble resulting in a complete inhibition of oxi-
dative phosphorylation. Cytochrome c is associated with the inner membrane of the mitochondria and interacts 
with redox partners of complex III and complex IV, which is a part of the mitochondrial electron transfer chain. 
We determined the expression levels of TOM20, cytochrome b and c, which are central for the regulation of 
Figure 1. Expression of mitochondrial electron transport chain (ETC) proteins in PHT cells with mTORC1 or 
mTORC2 inhibition. Protein expression of ETC complex I (NDUFB8), complex II (SDHB), III (UQCRC2), IV 
(COXII) and V (V-ATP5A in PHT cells transfected with either scramble (n = 4) or raptor (mTORC1 inhibition, 
n = 4) or rictor (mTORC2 inhibition, n = 4) siRNA. Full length Western blot is shown. The data are from a 
representative experiment, and similar results were obtained from three other experiments.
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mitochondrial function, following mTOR inhibition in PHT cells. As shown in Supplemental Fig. 4, inhibition of 
mTORC1 signaling decreased the expression of TOM20, cytochrome b and c as compared to control (n = 6/each 
group; Supplemental Fig. 4).
Inhibition of mTORC1 decreases mitochondrial respiration in cultured PHT cells. We assessed 
mitochondrial function in PHT cells by determining OCR following sequential addition of pharmacological 
inhibitors to probe the function of individual components of the respiratory chain. The design of these experi-
ment is provided in Supplemental Methods. To estimate the proportion of the basal OCR coupled to ATP syn-
thesis, ATP synthase (Complex V) was inhibited by oligomycin, which decreases the OCR rate to the extent to 
which the cells are using mitochondria to generate ATP. The remaining OCR is ascribed to proton leak across 
the mitochondrial membrane. To determine the maximal OCR that the cells can sustain, the proton ionophore 
FCCP was injected. Lastly, antimycin A was injected to inhibit electron flux through Complex III which causes a 
dramatic suppression of the OCR. The remaining OCR is attributable to O2 consumption due to the formation of 
mitochondrial ROS and non-mitochondrial sources. The reserve respiratory capacity was calculated as the max-
imal rate minus the basal rate and presents a parameter which is available to cells for increased work to cope with 
stress. As shown in Fig. 2 (n = 4/each group), inhibition of mTORC1 decreased the basal respiration (p = 0.02), 
ATP-coupled respiration (p = 0.04), maximum respiration (p = 0.01), reserve capacity (p = 0.04) and proton leak 
(p = 0.04) as compared to control. Non-mitochondrial respiration was not significantly affected (p = 0.08) by 
mTORC1 inhibition (Fig. 2).
No effect of mTORC2 inhibition on mitochondrial respiration in cultured PHT cells. We also 
studied the effects of mTORC2 inhibition on mitochondrial function in cultured PHT cells. Basal, ATP-coupled 
and maximum respiration, as well as reserve capacity, non-mitochondrial respiration, and proton leak were unaf-
fected by mTORC2 inhibition by rictor silencing (n = 4/each group; Fig. 3).
Activation of mTORC1 and 2 increases mitochondrial respiration in cultured PHT cells. Activation 
of mTORC1 and mTORC2 using DEPTOR silencing significantly increased basal respiration (p = 0.03), 
ATP-coupled respiration (p = 0.03), maximum respiration (p = 0.009), and reserve capacity (p = 0.005) as com-
pared to control. Non-mitochondrial respiration (p = 0.2) and proton leak (p = 0.2) were unaffected by activating 
mTORC1 and mTORC2 (n = 4/each group; Fig. 4).
Figure 2. Effect of mTORC1 inhibition on mitochondrial respiration in PHT cells. Mitochondrial respiration 
was measured in PHT cells at 90 hours of culture following inhibition of mTORC1 by silencing of raptor. 
Individual oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal respiration, non-
mitochondrial respiration, reserve capacity and proton leak) were calculated based on total cellular protein and 
expressed relative to control PHT cells (transfected with scramble siRNA). Data are presented as mean + S.E.M. 
*P < 0.05 vs scramble siRNA cells, paired student’s T-test, n = 4 independent experiments.
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Effect of mTOR on cellular ATP levels. The effect of mTOR inhibition on PHT cell ATP levels was exam-
ined. The cellular ATP content was decreased by 50% in raptor silenced cells as compared to control (P < 0.01, 
n = 6/each group; Fig. 5a). However, the cellular ATP levels were comparable between control and rictor silenced 
PHT cells (Fig. 5b). In contrast, ATP levels were significantly (P < 0.05, n = 6/each group) increased in mTOR 
activated PHT cells (DEPTOR silenced) as compared to control (Fig. 5c).
Mitochondrial DNA copy number. To explore the mechanism that may account for the decline in PHT 
cellular ATP levels following mTORC1 inhibition, we utilized a RT-PCR approach to measure changes in mito-
chondrial biogenesis (Fig. 5d–f). The mitochondrial DNA copy number was significantly decreased in raptor 
silenced cells as compared to control (P < 0001, n = 6/each group; Fig. 5d), whereas mTORC2 inhibition (rictor 
silencing) did not affect the mitochondrial biogenesis in PHT cells (Fig. 5e). In DEPTOR silenced cells, mito-
chondrial DNA copy number was significantly increased as compared to control (P < 0.05, n = 6/each group; 
Fig. 5f).
Mitochondrial citrate synthase activity. We also estimated the mitochondrial content by measuring cit-
rate synthase activity. mTORC1 inhibition showed a significant reduction in citrate synthase activity (P < 0.0001, 
n = 6/each group; Fig. 5g), whereas citrate synthase activity was comparable between rictor silenced and control 
PHT cells (Fig. 5h). DEPTOR silencing significantly increased the citrate synthase activity as compared to control 
(P < 0.01, n = 6/each group; Fig. 5i).
Visualization of mitochondria in PHT cells using immunofluorescence. To provide additional sup-
port for the idea that mTORC1 signaling influences mitochondrial biogenesis, we used confocal microscopy to 
visualize mitochondria in cultured PHT cells. We observed that in response to raptor silencing mitochondria 
content decreased as compared to control PHT cells (Fig. 6).
Placental mTORC1 signaling is associated with the protein expression of mitochondrial ETC 
complexes in human pregnancy. To explore the clinical relevance of our findings, we examined the rela-
tionship between placental mTORC1 signaling and the protein expression of mitochondrial electron transport 
chain complexes in placentas collected from control and IUGR pregnancies. The protein expression of ETC com-
plex I (Fig. 7a) and II-V (Supplementary Figs 5a–8a) were significantly reduced in IUGR placentas. Placental 
raptor and rictor expressions were significantly decreased in the IUGR as compared to control (Supplementary 
Fig. 9). In contrast, placental DEPTOR expression was increased in the IUGR group as compared to control 
(Supplementary Fig. 9). Placental mTORC1 functional readouts signaling in the same placentas has been reported 
Figure 3. Effect of mTORC2 inhibition on mitochondrial function in PHT cells. Mitochondrial respiration was 
measured in PHT cells at 90 hours of culture following inhibition of mTORC2 by silencing of rictor. Individual 
oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal respiration, non-mitochondrial 
respiration, reserve capacity and proton leak) were calculated based on total cellular protein and expressed 
relative to control PHT cells (transfected with scramble siRNA). Data are presented as mean + S.E.M., paired 
student’s T-test, n = 4 independent experiments.
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elsewhere20. With few exceptions, placental mTORC1 signaling functional readouts of phosphorylated 4E-BP1 
(Thr-37/46) and S6 kinase (Thr-389) were positively correlated with mitochondrial ETC complexes (Fig. 7 and 
Supplementary Figs 5–8). The 4E-BP1 protein prevents translation initiation by binding eukaryotic translation 
initiation factor 4E (eIF4E) and phosphorylation of 4E-BP1 interferes with this binding, thereby activating pro-
tein translation. As a consequence, both the increased total expression of 4E-BP1 and the decreased phosphoryl-
ation of 4E-BP1 at Thr37/46 will promote binding of eIF4E resulting in inhibition of cap-dependent translation 
initiation in the IUGR placenta. Placental 4E-BP1 expression negatively correlated with mitochondrial ECT com-
plexes I and V (Fig. 7 and Supplementary Figs 5–8).
Discussion
We report that mTORC1, but not mTORC2, is a positive regulator of mitochondrial oxidative phosphorylation in 
primary human trophoblast cells mediated by influencing mitochondrial biogenesis. These findings extend previ-
ous reports of mTORC1 regulation of mitochondrial respiration in cell lines to human primary non-proliferative 
cells. In addition, we provide evidence that placental protein expression of ETC complexes was decreased and 
positively correlated to mTOR signaling activity in IUGR. By controlling trophoblast ATP production, which is 
essential for energizing active transport and protein synthesis, mTORC1 links nutrient and O2 availability and 
growth factor signaling to placental function and fetal growth. Reduced placental mTOR activity may impair 
mitochondrial respiration and contribute to placental insufficiency in IUGR pregnancies.
The use of PHT cells contributes to the relevance of our studies to human physiology and the demonstration of 
decreased protein expression of mitochondrial ETC complexes in human IUGR placentas highlights the potential 
clinical impact of our findings. Although mTOR is known as the master regulator of protein translation, our data 
show that mTOR has a profound influence on trophoblast mitochondrial ETC gene expression, with mTORC1 and 
mTORC2 showing differential regulation. Importantly, mTORC1, but not mTORC2, constitutes a positive regulator of 
trophoblast mitochondrial respiration mediated by changes in the expression of genes representing all five complexes 
of the electron transport chain. By controlling trophoblast production of ATP, which is critical for active transport and 
protein synthesis, and regulating plasma membrane trafficking of amino acid transporters25, mTORC1 links nutrient 
and oxygen availability and growth factor signaling to placental function. Our findings are consistent with the pos-
sibility that reduced placental mTOR activity in IUGR18–20 may impair mitochondrial respiration and contribute to 
placental insufficiency in this pregnancy complication. However, the available literature assessing mitochondrial DNA 
and expression of ETC complexes in the human IUGR placenta is not entirely consistent. For example, whereas some 
investigators have reported that IUGR is associated with decreased placental mitochondrial DNA content49,50, others 
Figure 4. Effect of activation of mTORC1 and 2 on mitochondrial respiration in PHT cells. Mitochondrial 
respiration was measured in PHT cells at 90 hours of culture following activation of mTORC1/2 by silencing 
of DEPTOR. Individual oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal 
respiration, non-mitochondrial respiration, reserve capacity and proton leak) were calculated based on total 
cellular protein and expressed as relative to PHT cells (transfected with scramble siRNA). Data are presented as 
mean + S.E.M. *P < 0.05 vs scramble siRNA cells, paired student’s T-test, n = 4 independent experiments.
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found higher mitochondrial DNA content in the human IUGR placenta51–53. Furthermore, Mando52 and coworkers 
reported that mtDNA content and expression of genes encoding for ETC proteins were decreased whereas ETC protein 
expression was unaltered and ETC activity was increased in cultured trophoblast cells isolated from IUGR placentas52. 
The reasons for the divergent findings in the different studies remains to be established.
Figure 5. Regulation of PHT cell ATP levels, mitochondrial DNA (mtDNA) copy number, and citrate 
synthase activity by mTOR signaling. (a–c) ATP levels were normalized to total protein level of cell lysates. 
(d–f) Mitochondrial numbers assessed by mtDNA copy number. mtDNA copy number was normalized to 
nuclear DNA (nDNA) (β2-microglobulin) for each sample. (g–i) Mitochondrial numbers estimated by citrate 
synthase activity. Data are presented as mean + S.E.M. *P < 0.05 vs scramble siRNA cells, n = 6 independent 
experiments. The number of experiments (n) represents the number of placentas studied.
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Inhibition of mTORC1 resulted in a highly coordinated transcriptional response of genes related to oxidative 
phosphorylation, which is consistent with the finding that mitochondrial function was the top-ranked pathway 
affected by raptor silencing. Specifically, genes in all mitochondrial complexes were down-regulated in PHT cells 
Figure 6. Visualization of mitochondria in PHT cells using immunofluorescence. Trophoblast cells were 
transfected at 18 h in culture with scramble (a) or raptor (b) siRNA. At 90 h in culture, cells were incubated with 
mitochondrial dye and fixed and mitochondria (green) were visualized using immunofluorescence. The data are 
from a representative experiment, and similar results were obtained from three other experiments. Nuclei were 
counterstained using DAPI (4′,6-diamidino-2-phenylindole) (blue); scale bar 50 µm. (c) Histogram summarizes 
the syncytiotrophoblast mitochondrial staining intensity in PHT cells transfected with either scramble or raptor 
siRNA. In each section, at least five randomly selected microscopic fields were used to calculate staining density 
per mm2 using Image J and data were averaged to represent a single placenta. Values are given as mean + SEM; 
*P < 0.05 vs scramble siRNA; unpaired Student’s t-test; n = 4 placenta/each group.
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Figure 7. Correlation between placental mTORC1 functional readouts and protein expression of 
mitochondrial ETC complex I. (a) Protein expression of mitochondrial electron transport chain complexes 
in placental homogenates of control and IUGR group. Representative Full length Western blot is shown. (b) 
Relative expression of mitochondrial electron transport chain complex I expression in placental homogenates 
of control and IUGR. After normalization to β-actin, the mean density of C samples was assigned an arbitrary 
value of 1. Subsequently, individual IUGR density values were expressed relative to this mean. (c–e) Correlation 
between placental mTORC1 functional readouts S6KT-389 (c), 4E-BP1 T-37/46 (d) 4E-BP1 (e) and mitochondrial 
ETC complex I expression. r = Pearson correlation coefficient, n = Control, 19; IUGR, 25. Values are given as 
means ± S.E.M.; *P < 0.05 vs. control; unpaired Student’s t test.
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following mTORC1 inhibition. This effect is likely to be mediated, at least in part, by mTORC1 inhibition of mito-
chondrial biogenesis, as evidenced by decreased cellular ATP levels, citrate synthase activity and mitochondrial 
copy number in raptor silenced cells.
Previous studies show that muscle-specific knockout of raptor in mice results in down-regulation of mito-
chondrial gene expression and decreased oxidative capacity29. Furthermore, rapamycin treatment or knockdown 
of mTOR or raptor in muscle cells or in MCF7 cells decreases mitochondrial gene expression and oxygen con-
sumption27,45,46. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras 
homolog enriched in brain, resulting in inhibition of mTORC1. TSC2−/− knock out in MEFs exhibited hyperac-
tivation of mTORC1 signaling54 and an increased expression of mitochondrial genes that were downregulated by 
rapamycin27. Loss of TSC2 in MEF’s increased mitochondrial respiration and mitochondrial DNA content and 
ATP levels46. Furthermore, in the absence of DEPTOR, mTORC1 remains active, which promotes liver mito-
chondrial oxidative metabolism. Consistent with previous findings27,46, in the present study, we found that mTOR 
activation by silencing DEPTOR in PHT cells increased the mitochondrial oxidative phosphorylation and ATP 
synthesis. These results further support the finding that mTORC1 signaling positively controls mitochondrial 
gene expression and oxygen consumption in an mTORC2 independent manner. Taken together, our data in pri-
mary human trophoblast cells and previous studies in other cell systems demonstrate that mTORC1 controls 
mitochondrial respiration, thereby linking increased nutrient availability and activation of growth factor sign-
aling to increased capacity for cellular energy production in an integrated response to promote cellular growth.
Mitochondrial biogenesis also involves an increase of mitochondrial import55. In differentiating C2C12 cells 
overexpression of Tom20 increases and the inhibition of Tom20 decreases the mitochondrial import, demonstrat-
ing the critical importance of Tom20 in determining the mitochondrial capacity to important cytosolic proteins56. 
Furthermore, the use of anti-Tom20 antibodies reduces the import of several mitochondrial proteins57. In our 
study, the mitochondrial Tom20 protein level was reduced by mTORC1 inhibition, which may be secondary to 
the decreased mitochondrial number and/or as a result of mTORC1 directly regulating Tom20 expression.
To our knowledge, this is the first study showing mTORC1 regulation of mitochondrial function in troph-
oblast cells. However, the molecular mechanisms linking mTORC1 inhibition to decreased mitochondrial bio-
genesis in PHT cells remain to be established. Long-term inhibition of mTORC1 with rapamycin was found to 
decrease PGC-1α (Peroxisome-proliferator-activated receptor coactivator-1α) mediated gene transcription in 
muscle cells in vitro, possibly mediated by the yin-yang 1 (YY1) transcription factor27. As a result, mitochondrial 
DNA content and oxygen consumption were lowered27. Reduction in energetic capacity renders cells more sus-
ceptible to stressors58.
Placental mitochondrial dysfunction has been proposed to represent one mechanism underlying fetal pro-
gramming in cases of placental insufficiency5. In mouse embryos, altered mitochondrial function affects fetal 
and placental growth59, and conversely, restricted fetal growth induced by maternal under-nutrition in rats is 
associated with impaired placental mitochondrial function6. A multitude of nutrient transporters, including 
amino acid, vitamin and calcium transporters, mediate active transport across the placental barrier and therefore 
requires a continuous supply of ATP. Although a significant portion of trophoblast ATP is produced by the glyc-
olytic pathway, the majority is likely to be derived from mitochondrial respiration. Thus, impaired mitochondrial 
function and decreased placental ATP production3, may link placental mTORC1 inhibition in placental insuffi-
ciency18,22 to restricted fetal growth.
Figure 8. A proposed model linking mTORC1 inhibition, mitochondrial respiration and fetal growth 
restriction. Placental mTORC1 signaling is inhibited in fetal growth restriction, we speculate that decreased 
trophoblast mitochondrial respiration and ATP production may link placental mTORC1 inhibition in placental 
insufficiency to restricted fetal growth. Abbreviation: MVM: Microvillus plasma membrane; BM: Basal plasma 
membrane; mt: Mitochondria.
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We demonstrated that protein expression of mitochondrial ETC complexes were decreased in human IUGR 
placentas. In addition, placental mTORC1 signaling functional readouts were positively correlated with the pro-
tein expression of placental mitochondrial ETC complexes. These findings suggest that our study has relevance to 
clinically important pregnancy complications. In addition, given that trophoblast mitochondrial respiration can 
be directly modulated by mTOR signaling, we speculate that activation of placental mTOR signaling to promote 
energy production may be a target of interest in future development of novel intervention strategies in IUGR.
In conclusion, mTORC1, but not mTORC2, is a positive regulator of the trophoblast expression of genes 
encoding ETC proteins and mitochondrial respiratory function, likely mediated by effects on mitochondrial bio-
genesis. By controlling trophoblast production of ATP, which is critical for active transport and protein synthesis, 
and regulating plasma membrane trafficking of amino acid transporters25, mTOR functions as a placental nutrient 
sensor linking nutrient and oxygen availability and growth factor signaling to placental function and fetal growth. 
Because placental mTORC1 signaling is inhibited in fetal growth restriction, we speculate that decreased mito-
chondrial respiration induced by inhibition of mTORC1 signaling directly contributes to placental insufficiency 
in this pregnancy complication (Fig. 8).
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